Table 1 Clinical characteristic of 383 patients

Age (years old, \({\overline{\text{x}}} \pm {\text{s}}\))

61.91 ± 9.33

59.80 ± 9.36

0.09

Male (number, %)

177 (56.55)

41 (58.57)

0.76

Height (cm, \({\overline{\text{x}}} \pm {\text{s}}\))

165.45 ± 7.79

164.67 ± 9.39

0.52

Weight (kg, \({\overline{\text{x}}} \pm {\text{s}}\))

66.52 ± 9.68

82.36 ± 9.80

 < 0.001*

Systolic BP (mmHg, \({\overline{\text{x}}} \pm {\text{s}}\))

129.89 ± 18.33

135.46 ± 18.25

0.02^*

Diastolic BP (mmHg, \({\overline{\text{x}}} \pm {\text{s}}\))

79.02 ± 10.86

82.33 ± 9.23

0.02*

DM (number, %)

56 (17.89)

14 (20.00)

0.68

HBP (number, %)

29 (15.68)

41 (20.71)

0.2

Coronary stenosis[%,M(Q₁,Q₃)]

30 (0,50)

30 (0, 40)

0.13

Hyperlipidemia (number, %)

31 (9.90)

6 (8.57)

0.73

hs-cTnT(ng/L, \({\overline{\text{x}}} \pm {\text{s}}\))

6(4,9)

8(6,11)

 < 0.001*

NT-pro BNP[pg/ml, M(Q₁,Q₃)]

48.8(25.4,104)

37.05(14.60,71.30)

0.02*

CK-MB[U/L,M(Q₁,Q₃)]

15(13,19)

16(13,19)

0.17

CRP[mg/L, M(Q₁,Q₃)]

0.90(0.40,2.15)

1.25(0.70,3.00)

0.02*

D-dimer[mg/L, M(Q₁,Q₃)]

0.19(0.19,0.29)

0.19(0.19,0.25)

0.51

ALT [U/L, M(Q₁,Q₃)]

18(14,26)

23(17,33)

0.01*

AST [U/L, M(Q₁,Q ₃)]

19(16,23)

19(16,24)

0.52

GFR (ml/min/1.73m²,\({\overline{\text{x}}} \pm {\text{s}}\)

76.07 ± 17.57

78.24 ± 16.80

0.35

Creatinine[μmol/L, M(Q₁,Q₃)]

73(61,84)

74(62,85)

0.76

Glucose[mmol/L,M(Q₁,Q₃)]

5.7 (5.1,7.3)

5.8(5.1,6.8)

0.95

Glycated albumin(%,\({\overline{\text{x}}} \pm {\text{s}}\))

14.66 ± 2.94

14.70 ± 3.68

0.91

HbA₁c[%, M(Q₁,Q₃)]

5.7(5.4,6.1)

5.8(5.6,6.4)

0.03*

TC (mmol/L, \({\overline{\text{x}}} \pm {\text{s}}\))

4.02 ± 1.11

4.08 ± 1.05

0.7

TG (mmol/L, \({\overline{\text{x}}} \pm {\text{s}}\))

1.71 ± 1.17

1.85 ± 1.07

0.34

HDL-c(mmol/L, \({\overline{\text{x}}} \pm {\text{s}}\))

1.22 ± 0.32

1.13 ± 0.28

0.02*

LDL-c(mmol/L, \({\overline{\text{x}}} \pm {\text{s}}\))

2.06 ± 0.86

2.18 ± 0.89

0.31

TSH (μIU/ml, \({\overline{\text{x}}} \pm {\text{s}}\))

2.16 ± 1.59

1.94 ± 1.42

0.27